Melbourne, Australia (PRWEB) August 10, 2013
The Online Pharmaceutical Sales industry has been relatively stagnant over the past five years due to heavy competitive and supply side pressures from multiple sources. Upstream manufacturers are withdrawing unprofitable drugs from the market, specialist retailers are successfully drawing away industry customers, physical pharmacies are moving online and supermarkets are making inroads into general medicine sales and a range of personal care items. In addition, industry players engage in constant price wars in non-prescription medicines and personal care items. According to IBISWorld industry analyst Ryan Lin, “Over the past five years, price has become an increasingly important issue for the industry”. Online pharmacies are competing against big-box discount pharmacies like Chemist Warehouse. The industry is unable to provide value added services like bricks-and-mortar stores, and it cannot out-price discount specialists. However, the industry has received a boost from sales of associated personal care items, especially personal health products. Over the five years through 2013-14, industry revenue is expected to grow at an annualised 0.8% to reach $213.6 million. Revenue is projected to grow by 0.2% in 2013-14 as consumers look towards specialty retailers and other distribution sources as the economy strengthens.
“The industry is characterised by a low degree of market share concentration, with no one player expected to account for a significant share of industry sales," says Lin. This reflects the small-scale nature of the industry, the regulatory environment that the industry operates in and the associated legal structures of the businesses that operate within it.
The Online Pharmaceutical Sales industry has exhibited a slight counter-cyclical trend, with an increase in online sales as cheaper and wider ranging goods are preferred when consumers face economic and financial uncertainties. As a result, the industry is projected to perform poorly over the coming five years. Despite a number of favourable consumer trends, the industry will fail to capture potential growth. Continual pressure from external and internal competitive factors has forced the industry to downsize, with many players leaving and consolidation occurring within the remaining players. Consumers are also increasingly willing to purchase industry products from alternative sources such as online specialty stores and their respective bricks-and-mortar outlets.
For more information, visit IBISWorld’s Online Pharmaceutical Sales report in Australia industry page.
Follow IBISWorld on Twitter: http://twitter.com/#!/ibisworldau
IBISWorld Industry Report Key Topics
Companies in this industry primarily sell pharmaceutical products via the internet. This includes prescription and non-prescription medicines and associated personal care items. The industry excludes establishments that may have a dual presence (both physical stores and online operations).
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Technology & Systems
Regulation & Policy
About IBISWorld Inc.
Recognised as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every Australian industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Melbourne, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com.au or call (03) 9655 3886.